<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02594059</url>
  </required_header>
  <id_info>
    <org_study_id>2012/56</org_study_id>
    <nct_id>NCT02594059</nct_id>
  </id_info>
  <brief_title>Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis</brief_title>
  <acronym>Endoth-FPI</acronym>
  <official_title>Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the peripheral endothelial function in adult patients with
      idiopathic pulmonary fibrosis (IPF) and the relationship between the peripheral endothelial
      function and the severity of the IPF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary criteria is the peripheral endothelial function that will be assessed by the
      measure of flow-mediated dilation (reactive hyperemia-peripheral artery tone index). The
      pulmonary function will be assessed by the measures of the forced expiratory volume at one
      second (FEV1), the forced vital capacity (FVC) and the total lung capacity (TLC) and the
      diffusing capacity of the lung for carbon monoxide (DLCO). The dyspnea will be assessed with
      the New York Heart Association (NYHA) score. The exercise capacity will be assessed by the
      6-min walk test. Pulmonary arterial pressure will be recorded through cardiac echography or
      catheterization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measure of reactive hyperemia-peripheral artery tone index</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>endothelial function</measure>
    <time_frame>1, 2 and 3 years</time_frame>
    <description>measure of reactive hyperemia-peripheral artery tone index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>measure of reactive hyperemia-peripheral artery tone index</measure>
    <time_frame>3 years</time_frame>
    <description>measure of reactive hyperemia-peripheral artery tone index at IPF exacerbation or PAHT's occurence</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Pulmonary idiopathic fibrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with pulmonary idiopathic fibrosis according to ATS/ERS 2011's criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>endothelial function</intervention_name>
    <description>measure of reactive hyperemia-peripheral artery tone index</description>
    <arm_group_label>Pulmonary idiopathic fibrosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IPF according to ATS/ERS 2011's criteria

          -  Stable IPF (no reduction of FVC or DLCO of more than 10% and 15% respectively)

        Exclusion Criteria:

          -  Patients with a significant disease other than IPF. A significant disease is defined
             as a disease which, in the opinion of the investigator, may influence the results of
             the trial.

          -  Pregnant or nursing women.

          -  Non-pulmonary fibrosis

          -  treatment by pulmonary vasodilators that cannot be stopped for 24 hours for the
             assessment of endothelial function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe Devillier, MD PhD</last_name>
    <phone>33 1 46 25 27 91</phone>
    <email>p.devillier@hopital-foch.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène Neveu, MD</last_name>
    <email>h.neveu@hopital-foch.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Europeen Georges Pompidou, dpt of pneumology</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Israel-Biet, MD PhD</last_name>
      <email>dominique.israel-biet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Neveu, MD</last_name>
      <email>h.neveu@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2015</study_first_submitted>
  <study_first_submitted_qc>October 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2015</study_first_posted>
  <last_update_submitted>September 11, 2016</last_update_submitted>
  <last_update_submitted_qc>September 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endothelial function, idiopathic pulmonary fibrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

